De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning
Authors
Keywords
-
Journal
BMC Chemistry
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-02
DOI
10.1186/s13065-021-00737-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bidirectional Molecule Generation with Recurrent Neural Networks
- (2020) Francesca Grisoni et al. Journal of Chemical Information and Modeling
- Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
- (2020) Xin Liu et al. Journal of Genetics and Genomics
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Assessing the impact of generative AI on medicinal chemistry
- (2020) W. Patrick Walters et al. NATURE BIOTECHNOLOGY
- De novo generation of hit-like molecules from gene expression signatures using artificial intelligence
- (2020) Oscar Méndez-Lucio et al. Nature Communications
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- The Architecture of SARS-CoV-2 Transcriptome
- (2020) Dongwan Kim et al. CELL
- Déjà vu: Stimulating open drug discovery for SARS-CoV-2
- (2020) Sean Ekins et al. DRUG DISCOVERY TODAY
- Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
- (2020) André Fischer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- SMILES-based deep generative scaffold decorator for de-novo drug design
- (2020) Josep Arús-Pous et al. Journal of Cheminformatics
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
- (2020) Yang Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses
- (2020) Sirin Theerawatanasirikul et al. ANTIVIRAL RESEARCH
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19
- (2020) Kiran Bharat Lokhande et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
- (2020) Sophie Juul et al. PLOS MEDICINE
- Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
- (2020) Mohamed Mahdi et al. Virology Journal
- GuacaMol: Benchmarking Models for de Novo Molecular Design
- (2019) Nathan Brown et al. Journal of Chemical Information and Modeling
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Analyzing Learned Molecular Representations for Property Prediction
- (2019) Kevin Yang et al. Journal of Chemical Information and Modeling
- Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings
- (2019) Rafael Ferreira Dantas et al. Expert Opinion on Drug Discovery
- De Novo Design of Bioactive Small Molecules by Artificial Intelligence
- (2018) Daniel Merk et al. Molecular Informatics
- Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
- (2018) Andreas Mayr et al. Chemical Science
- ChEMBL: towards direct deposition of bioassay data
- (2018) David Mendez et al. NUCLEIC ACIDS RESEARCH
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
- (2016) Jonathan B. Baell JOURNAL OF NATURAL PRODUCTS
- Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras
- (2016) Lili Kuo et al. JOURNAL OF VIROLOGY
- Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research
- (2015) Martin Pouliot et al. JOURNAL OF MEDICINAL CHEMISTRY
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets
- (2015) Takaya Saito et al. PLoS One
- Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
- (2013) Mark Turlington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction.
- (2013) Robert P. Sheridan Journal of Chemical Information and Modeling
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
- (2009) Peter Ertl et al. Journal of Cheminformatics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search